Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Shares Sold by Horizon Bancorp Inc. IN

Horizon Bancorp Inc. IN cut its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 27.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 487 shares of the company’s stock after selling 184 shares during the quarter. Horizon Bancorp Inc. IN’s holdings in Invesco Pharmaceuticals ETF were worth $40,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. FMR LLC boosted its stake in shares of Invesco Pharmaceuticals ETF by 29.4% during the 3rd quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after acquiring an additional 240 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $1,163,000. Arete Wealth Advisors LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $402,000. Secure Asset Management LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $229,000. Finally, Joseph Group Capital Management boosted its stake in shares of Invesco Pharmaceuticals ETF by 10.8% during the 2nd quarter. Joseph Group Capital Management now owns 13,001 shares of the company’s stock worth $1,069,000 after acquiring an additional 1,272 shares in the last quarter.

Invesco Pharmaceuticals ETF Stock Up 0.4 %

PJP opened at $82.52 on Tuesday. The firm has a market cap of $279.74 million, a PE ratio of 21.48 and a beta of 0.61. The business has a fifty day simple moving average of $85.03 and a 200-day simple moving average of $85.57. Invesco Pharmaceuticals ETF has a fifty-two week low of $75.33 and a fifty-two week high of $89.87.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.